Cargando…
Chronic intermittent hypobaric hypoxia attenuates monocrotaline-induced pulmonary arterial hypertension via modulating inflammation and suppressing NF-κB/p38 pathway
OBJECTIVE(S): Inflammation is involved in various forms of pulmonary arterial hypertension (PAH). Although the pathophysiology of PAH remains uncertain, NF-κB and p38 mitogen-activated protein kinase (p38 MAPK) has been reported to be associated with many inflammatory mediators of PAH. This study ai...
Autores principales: | Gao, Lei, Liu, Jun, Hao, Yongmei, Zhao, Zengren, Tan, Huilian, Zhang, Jie, Meng, Ning, Zheng, Qinghou, Wang, Zhen, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817167/ https://www.ncbi.nlm.nih.gov/pubmed/29511490 http://dx.doi.org/10.22038/ijbms.2018.25399.6280 |
Ejemplares similares
-
Hypobaric Intermittent Hypoxia Attenuates Hypoxia-induced Depressor Response
por: Cui, Fang, et al.
Publicado: (2012) -
Correction: Hypobaric Intermittent Hypoxia Attenuates Hypoxia-induced Depressor Response
por: Cui, Fang, et al.
Publicado: (2013) -
Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways
por: Yu, Min, et al.
Publicado: (2022) -
Chronic Intermittent Hypobaric Hypoxia Enhances Bone Fracture Healing
por: Zhang, Li, et al.
Publicado: (2021) -
Preconditioning With Intermittent Hypobaric Hypoxia Attenuates Stroke Damage and Modulates Endocytosis in Residual Neurons
por: Wan, Yaqi, et al.
Publicado: (2021)